Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 27 Sep 2026 · Editorial standards

At a glance

Children's Hospital of Fudan University is the lead sponsor of 87 current clinical trials in our China register. 64 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Aspirin, IVIG and Infliximab. The most-studied condition is Kawasaki Disease.

ClinicalTrials.gov trials by status

Recruiting6474%
Not yet open1011%
Active, closed89%
By invitation56%

Trials by phase

Observational3743%
Not applicable3439%
Phase 467%
Phase 356%
Phase EARLY_PHASE133%
Phase 2/311%
Phase 111%

Clinical trials sponsored by Children's Hospital of Fudan University

87 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
PK/PD of Caspofungin in Children Severe Infection NCT04961593 · Pharmacokinetics, Infection, Fungal Drug: Caspofungin	Observational	Recruiting	2022-10	China
Dupilumab Therapy for EGIDs NCT07257835 · ClinicalTrials.gov ↗ · Eosinophilic Gastrointestinal Disorders (EGIDs)	Observational	Recruiting	2025-01	China
Child-Parent Familial Hypercholesterolemia Screening NCT04529967 · ClinicalTrials.gov ↗ · Familial Hypercholesterolemia	Observational	Recruiting	2025-04	China
Urine and Ultrasound Screening for Kidney Disease in Children NCT06018831 · ClinicalTrials.gov ↗ · Kidney Diseases, Diagnostic Techniques, Ultrasound	Not applicable	Recruiting	2022-04	China
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma NCT05351216 · ClinicalTrials.gov ↗ · Kaposiform Hemangioendothelioma	Observational	Recruiting	2021-03	China
A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children NCT04955210 · ClinicalTrials.gov ↗ · Critical Illness, Severe Sepsis	Observational	Recruiting	2022-04	China
AN69ST Verse PS in CBP in Septic Children NCT05692011 · ClinicalTrials.gov ↗ · Sepsis	Observational	Recruiting	2025-10	China
Validation of the Effectiveness of the CFIR - ERIC Matching Tool in Implementation Research NCT07184489 · ClinicalTrials.gov ↗ · Infusions, Intravenous, Implementation Science	Not applicable	Recruiting	2025-06	China
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty NCT06510764 · ClinicalTrials.gov ↗ · Precocious Puberty, Treatment, Alternative Medicine	Phase 3	Recruiting	2024-09	China
The China Neonatal Genomes Project NCT03931707 · ClinicalTrials.gov ↗ · Newborn, Hereditary Disease, Genetic Predisposition to Disease	Observational	Recruiting	2016-08	China
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children NCT04794595 · ClinicalTrials.gov ↗ · Sepsis, Children, Only	Observational	Recruiting	2020-12	China
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU NCT06742060 · ClinicalTrials.gov ↗ · Diabetes Insipidus, Neurohypophyseal, Copeptin Blood Levels, Copeptin	Observational	Recruiting	2024-11	China
Epidemiology Study on Neonatal Seizure NCT02552511 · ClinicalTrials.gov ↗ · Seizures	Observational	Recruiting	2015-09	China
Optimizing Early Nutrition Management of Extremely and/or Very Preterm Infants NCT07538999 · ClinicalTrials.gov ↗ · Nutrition Intervention, Quality Improvement, Preterm Infant	Not applicable	Recruiting	2026-04	China
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty NCT04528303 · ClinicalTrials.gov ↗ · Diarrhea, Infantile, Enteropathy	Not applicable	Recruiting	2024-05	China
PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection NCT04961580 · ClinicalTrials.gov ↗ · Sepsis, Antibiotic Reaction	Observational	Recruiting	2022-10	China
Phenotype and Multi-omics Analysis of Children With Congenital Diarrhea and Enteropathy in China NCT06356545 · ClinicalTrials.gov ↗ · Diarrhea Infantile	Observational	Recruiting	2024-04	China
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock NCT03948048 · ClinicalTrials.gov ↗ · Septic Shock, Extracorporeal Membrane Oxygenation Complication	Observational	Recruiting	2020-08	China
Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children NCT06500078 · ClinicalTrials.gov ↗ · Cardiovascular Syndrome, Metabolic	Not applicable	Recruiting	2024-07	China
Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura NCT03647852 · ClinicalTrials.gov ↗ · Henoch-Schönlein Purpura Drugs: IVIG, Methylprednisolone	Not applicable	Recruiting	2019-09	China
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease NCT05643651 · ClinicalTrials.gov ↗ · Kawasaki Disease, Coronary Artery Aneurysm Drugs: Aspirin, Clopidogrel, Rivaroxaban	Phase 4	Recruiting	2025-06	China
Standardized Nutritional Management of Pediatric Patients With Solid Tumors NCT06730204 · ClinicalTrials.gov ↗ · Tumor, Solid, Children, Nutritional Intervention	Not applicable	Recruiting	2023-07	China
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes NCT04532346 · ClinicalTrials.gov ↗ · Interstitial Lung Disease, Surfactant Dysfunction Drug: Hydroxychloroquine	Phase EARLY_PHASE1	Recruiting	2024-09	China
Enteral Nutrition in Infants With Ileostomy NCT04707443 · ClinicalTrials.gov ↗ · Nutrition of Ileostomy Infants	Observational	Recruiting	2021-07	China
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm NCT04850456 · ClinicalTrials.gov ↗ · Critical Illness, Sepsis, Severe	Observational	Recruiting	2024-10	China
The Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years NCT05040542 · ClinicalTrials.gov ↗ · Brain Development, Behavior Disorders, Child, Intellectual Developmental Disorders	Observational	Recruiting	2021-08	China
Development of Prosocial Behaviors and Related Brain Network in Infants of High and Low Risk of ASD NCT06329245 · ClinicalTrials.gov ↗ · Autism or Autistic Traits, Healthy	Observational	Recruiting	2024-04	China
Magnetoencephalography in Children NCT06668519 · ClinicalTrials.gov ↗ · Epilepsy, Intracranial Tumors, Cerebrovascular Disease	Observational	Recruiting	2024-09	China
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy NCT05925309 · ClinicalTrials.gov ↗ · Biliary Atresia, Cholangitis, Anti-Bacterial Agents Drugs: Cefaclor, Imipenem, Meropenem	Not applicable	Recruiting	2023-07	China
Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease NCT06207552 · ClinicalTrials.gov ↗ · Fabry Disease	Phase EARLY_PHASE1	Recruiting	2024-02	China
Effects of Auricular Acupressure Versus Intermittent Dietary Restriction in Children With Gastric Heat and Dampness Obstruction NCT05847478 · ClinicalTrials.gov ↗ · Obesity, Childhood	Not applicable	Recruiting	2023-06	China
Evidence-based Practice in the Management of Gastric Tube Placement in Children NCT07038538 · ClinicalTrials.gov ↗ · Hospitalized Children, Nursing, Enteral Nutrition Therapy	Not applicable	Recruiting	2025-06	China
Effect of Developmental Care on Very Low Birth Weight Infants NCT06515574 · ClinicalTrials.gov ↗ · Intervention	Not applicable	Recruiting	2024-08	China
Application of Early Bundle Management of Mechanical Ventilation to Prevent Ventilator Dependence in Children NCT06125210 · ClinicalTrials.gov ↗ · Prolonged Mechanical Ventilation	Not applicable	Recruiting	2024-09	China
Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease NCT07115108 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Enteral Nutrition, Pediatrics	Not applicable	Recruiting	2025-10	China
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia NCT05848310 · ClinicalTrials.gov ↗ · Biliary Atresia, Prognosis	Observational	Recruiting	2023-10	China
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children NCT04535661 · ClinicalTrials.gov ↗ · Carbapenem-Resistant Enterobacteriaceae Infection	Observational	Recruiting	2021-03	China
Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD NCT05901558 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder, Therapy	Not applicable	Recruiting	2023-06	China
Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder NCT07708246 · ClinicalTrials.gov ↗ · Autism, Intervention (Training) Condition, Social Cognition	Not applicable	Recruiting	2025-06	China
Thalidomide Therapy for VEOIBD NCT06382519 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases Drug: Thalidomide	Observational	Recruiting	2024-05	China
Top Down Versus Step up in Pediatric Ulcerative Colitis NCT04999228 · ClinicalTrials.gov ↗ · Ulcerative Colitis, Infliximab, Children Drug: Infliximab	Phase 4	Recruiting	2021-11	China
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease NCT06978439 · ClinicalTrials.gov ↗ · Kawasaki Disease, Pilot Study, Coronary Artery Aneurysm Drug: Rivaroxaban	Phase 4	Recruiting	2024-01	China
The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children NCT06890143 · ClinicalTrials.gov ↗ · Pediatric Hereditary Kidney Diseases Drug: Dapagliflozin	Phase 3	Recruiting	2025-03	China
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia NCT05072626 · ClinicalTrials.gov ↗ · Biliary Atresia, Infant, Nutrition Support	Observational	Recruiting	2021-10	China
Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units NCT02551081 · ClinicalTrials.gov ↗ · Genetic Disease, Multiple Malformation, Congenital Malformation	Observational	Recruiting	2015-10	China
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years NCT06993636 · ClinicalTrials.gov ↗ · Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban	Observational	Recruiting	2023-01	China
Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development NCT06908174 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder, Healthy	Observational	Recruiting	2025-04	China
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities NCT07530640 · ClinicalTrials.gov ↗ · Kawasaki Disease, Coronary Artery Abnormalities Drug: Atorvastatin	Phase 3	Recruiting	2026-06	China
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections NCT04923828 · ClinicalTrials.gov ↗ · Severe Infection	Observational	Recruiting	2023-12	China
Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness NCT04905537 · ClinicalTrials.gov ↗ · Genetic Screening, Hereditary Disease, Newborn	Observational	Recruiting	2021-01	China
High-Intensity Interval Training(HIIT) on Cardio-metabolic Risk in School-age Children NCT06416488 · ClinicalTrials.gov ↗ · Cardiovascular Syndrome, Metabolic	Not applicable	Recruiting	2024-07	China
The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics NCT05791604 · ClinicalTrials.gov ↗ · Prader-Willi Syndrome	Not applicable	Recruiting	2023-04	China
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes NCT06198725 · ClinicalTrials.gov ↗ · Type 1 Diabetes	Not applicable	Recruiting	2024-01	China
Neonatal Neurologic Intensive Care Network of China NCT02544100 · ClinicalTrials.gov ↗ · Neonatal Encephalopathy, Suspected Neonatal Encephalopathy	Observational	Recruiting	2015-09	China
Etiology and Treatment of Neonatal Seizure NCT03822741 · ClinicalTrials.gov ↗ · Seizures, Seizure Disorder, Seizure Newborn	Observational	Recruiting	2016-08	China
A Long-term Follow-up Study in Participants Who Received CS-101 NCT06479616 · ClinicalTrials.gov ↗ · Beta-Thalassemia	Not applicable	Recruiting	2024-06	China
Indicators and Evaluation of Efficacy of Yin-nourishing and Fire-reducing Chinese Medicine for Girls With Rapid Progression of Early Puberty NCT06820931 · ClinicalTrials.gov ↗ · Puberty Changes	Phase 4	Recruiting	2025-01	China
ECMO Treatment of Children in China in the Past 10 Years NCT04709432 · ClinicalTrials.gov ↗ · Extracorporeal Membrane Oxygenation, Child, Only	Observational	Recruiting	2021-01	China
Close Loop Smart Weaning for INO With PPHN NCT06832163 · ClinicalTrials.gov ↗ · Persistent Pulmonary Hypertension of the Newborn, Inhaled Nitric Oxide	Not applicable	Recruiting	2025-10	China
How Early Mobilization Impacts on Diaphragm Thickness in Critically Ill Children NCT04534296 · ClinicalTrials.gov ↗ · Mechanical Ventilation Complication, Ventilator-induced Diaphragm Dysfunction	Not applicable	Recruiting	2021-04	China
Combined Immunosuppression for Pediatric Crohn's Disease NCT05043870 · ClinicalTrials.gov ↗ · Crohn Disease, Infliximab, Immunosuppression Drug: Infliximab	Phase 4	Recruiting	2022-10	China
Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology NCT05306509 · ClinicalTrials.gov ↗ · Solid Tumor, Hematological Malignancies	Not applicable	Recruiting	2022-08	China
Application of Child Life Services in Pediatric Skin Prick Test NCT07319273 · ClinicalTrials.gov ↗ · Hypersensitivity, Pediatrics	Not applicable	Recruiting	2026-03	China
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM NCT03835312 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes	Not applicable	Recruiting	2019-02	China
Blood Purification in Septic Children NCT05595239 · ClinicalTrials.gov ↗ · Sepsis, Blood Purification	Not applicable	Not yet open	2026-07	China
Multicenter Validation Study on Autism Screening Using a Machine-assisted System NCT07006948 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders	Observational	Not yet open	2025-09	China
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease NCT07686770 · ClinicalTrials.gov ↗ · Kawasaki Disease Drugs: Aspirin, Firsekibart, IVIG	Phase 2/3	Not yet open	2026-08	China
YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases NCT07439029 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus (SLE), Diffuse Systemic Sclerosis, Idiopathic Inflammatory Myopathies (IIMs) Drug: YTS109 cell	Phase 1	Not yet open	2026-03	China
Clinical Study of Traditional Chinese Medicine in the Treatment of Phlegm-dampness Intrinsic Precocious Puberty NCT07637019 · ClinicalTrials.gov ↗ · Precocious Puberty	Not applicable	Not yet open	2026-07	China
Clinical Implementation of the Group Standard for Enteral Feeding Care in Critically Ill Children NCT07441746 · ClinicalTrials.gov ↗ · Clinical Implementation, Standardized Tube Feeding Care, Enteral Nutrition	Not applicable	Not yet open	2026-03	China
Evaluating the Safety and Efficacy of Decitabine in the Treatment of XMEN Patients NCT07555405 · ClinicalTrials.gov ↗ · MAGT1 Deficiency Drug: Decitabine	Phase 4	Not yet open	2026-04	China
CS-206 in Patients With Sickle Cell Disease NCT07000318 · ClinicalTrials.gov ↗ · Sickle Cell Disease	Phase EARLY_PHASE1	Not yet open	2026-09	China
Rituximab in the First Episode of Paediatric Nephrotic Syndrome NCT05850546 · ClinicalTrials.gov ↗ · Steroid-Sensitive Nephrotic Syndrome Drugs: Prednisolone/Prednisone, Rituximab	Phase 3	Not yet open	2025-03	China
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome NCT07765914 · ClinicalTrials.gov ↗ · Nephrotic Syndrome Drug: Zuberitamab	Phase 3	Not yet open	2026-08	China
Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery NCT06747546 · Congenital Heart Disease (CHD), Cardiopulmonary Bypass, Children	Not applicable	By invitation	2025-01	China
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up Study NCT07762729 · ClinicalTrials.gov ↗ · Gut Microbiota, Early Child Development	Observational	By invitation	2023-11	China
Scalp Acupuncture Treatment for Chronic Tic Disorders in Children NCT06924918 · ClinicalTrials.gov ↗ · Tic Disorder	Not applicable	By invitation	2025-08	China
Development of an Early Warning Model for Intensive Care Unit-Acquired Weakness in Mechanically Ventilated Children NCT07150637 · ClinicalTrials.gov ↗ · ICU Acquired Weakness	Observational	By invitation	2026-03	China
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level NCT07150650 · ClinicalTrials.gov ↗ · ICU Acquired Weakness	Observational	By invitation	2026-03	China
Midline Catheter Study NCT07610681 · ClinicalTrials.gov ↗ · Child Health	Observational	Active, closed	2026-03	China
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes NCT03936829 · ClinicalTrials.gov ↗ · Lipodystrophy Acquired, Type1diabetes Drug: Cyclophosphamide	Not applicable	Active, closed	2019-04	China
Focus-out Glasses on Emmetropization in Chinese Children NCT05689567 · ClinicalTrials.gov ↗ · Emmetropization, Myopia, Hyperopia	Not applicable	Active, closed	2023-03	China
Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis NCT06316609 · ClinicalTrials.gov ↗ · Atopic Dermatitis	Observational	Active, closed	2016-06	China
Clinical Cohort Study of DHA in Neurodevelopmental Disorders NCT05841927 · ClinicalTrials.gov ↗ · Autism or Autistic Traits	Not applicable	Active, closed	2020-12	China
Research on the Application of Decision Tree in Child Life NCT07325890 · ClinicalTrials.gov ↗ · Psychosocial Intervention, Non-Randomized Controlled Trials	Not applicable	Active, closed	2025-12	China
Mindfulness Intervention for Psychological and Family Dynamics in Children with Body-Focused Repetitive Behaviors NCT06777212 · ClinicalTrials.gov ↗ · Mindfulness Skills, Psychosocial Education	Not applicable	Active, closed	2025-01	China
Social Cognition in Children and Adolescents With Autism Spectrum Disorder NCT07692022 · ClinicalTrials.gov ↗ · Autism	Observational	Active, closed	2025-01	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Children's Hospital of Fudan University trials

23 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Children's Hospital of Fudan University trials

147 conditions

Kawasaki Disease5Sepsis4 Children3 Autism Spectrum Disorder3Coronary Artery Aneurysm3Autism3Biliary Atresia3Critical Illness2Precocious Puberty2Newborn2Hereditary Disease2Children, Only2Seizures2Cardiovascular Syndrome, Metabolic2ICU Acquired Weakness2Autism or Autistic Traits2Healthy2Enteral Nutrition2Pediatrics2Infliximab2Rivaroxaban2Pharmacokinetics1Infection, Fungal1Congenital Heart Disease (CHD)1

By trial register

Register	Trials	Recruiting
Clinical trials in China	87	64

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Kawasaki Disease

Sponsor	Trials
Meyer Children's Hospital IRCCS	2
West China Second University Hospital	2

Sponsors with the most current trials registered for this condition.

Questions about Children's Hospital of Fudan University trials

How many clinical trials does Children's Hospital of Fudan University sponsor?

Children's Hospital of Fudan University is the lead sponsor of 87 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Children's Hospital of Fudan University trials recruiting?

Yes. 64 of its 87 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Children's Hospital of Fudan University testing?

Its current trials name 23 drugs and biologicals as interventions. The most frequent are Aspirin (2), IVIG (2), Infliximab (2), Methylprednisolone (2) and Rivaroxaban (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Children's Hospital of Fudan University clinical trials